Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer. | Ther Adv Med Oncol | 2023 | 37667782 | PubTator, text mining | PubMed |
| Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability. | Oncologist | 2023 | 37665782 | PubTator, text mining | PubMed |
| Value of Antibody Drug Conjugates for Gynecological Cancers: A Modern Appraisal Following Recent FDA Approvals. | Int J Womens Health | 2023 | 37663226 | PubTator, text mining | PubMed |
| Advances in immunotherapy for triple-negative breast cancer. | Mol Cancer | 2023 | 37660039 | PubTator, text mining | PubMed |
| Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer. | Breast Cancer (Dove Med Press) | 2023 | 37644916 | PubTator, text mining | PubMed |
| Recent advances in targeted strategies for triple-negative breast cancer. | J Hematol Oncol | 2023 | 37641116 | PubTator, text mining | PubMed |
| Exploration of the antibody-drug conjugate clinical landscape. | MAbs | 2023 | 37639687 | PubTator, text mining | PubMed |
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial. | Lancet | 2023 | 37633306 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload. | Pharmaceutics | 2023 | 37631374 | PubTator, text mining | PubMed |
| A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer. | Pharmaceutics | 2023 | 37631234 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy. | Pharmaceutics | 2023 | 37631232 | PubTator, text mining | PubMed |
| Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy. | Int J Mol Sci | 2023 | 37629147 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Salivary Gland Cancer: Correlation with the Biological Behavior. | Diagnostics (Basel) | 2023 | 37627911 | PubTator, text mining | PubMed |
| Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer. | Biomolecules | 2023 | 37627272 | PubTator, text mining | PubMed |
| Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy. | Cancers (Basel) | 2023 | 37627044 | PubTator, text mining | PubMed |
| Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation. | Biomedicines | 2023 | 37626821 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals small extracellular vesicles derived from malignant cells that contribute to angiogenesis in human breast cancers. | J Transl Med | 2023 | 37626402 | PubTator, text mining | PubMed |
| Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma. | Curr Oncol | 2023 | 37623017 | PubTator, text mining | PubMed |
| Organoid models of the pituitary gland in health and disease. | Front Endocrinol (Lausanne) | 2023 | 37614709 | PubTator, text mining | PubMed |
| miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis. | Sci Rep | 2023 | 37604948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=51